Thermo Fisher Scientific to Showcase Mass Spectrometry LIMS Solutions at the Inaugural Applied Pharmaceutical Analysis Conference to be Held in India

The conference will showcase the latest pharmaceutical research and development technologies and will feature topics in discovery and regulated bioanalysis, biotransformation, and process chemistry. The Thermo Scientific TSQ Module for Watson Laboratory Information Management System (LIMS) will be highlighted at the conference, which will be held at the Hyderabad International Convention Centre in Hyderabad, India, February 21 - 24, 2010.

“We are excited to be an integral part of such an important conference which will bring together the scientific communities and technologies from around the world to advance pharmaceutical research and development on a global scale. These collaborations will enable us to continually address the challenges faced by the pharmaceutical industry today, as well as anticipate and prepare for the needs of the future,” states Koos van der Steuijt, country leader at Thermo Fisher Scientific in Mumbai, India.

Thermo Fisher Scientific will feature its new TSQ Module™ which works with industry-leading Watson™ LIMS and Thermo Scientific triple stage quadrupole mass spectrometers to manage the LC-MS/MS bioanalytical workflow from beginning to end. This industry-first integration enables direct data acquisition, peak integration and re-integration, storage, archiving, and reporting of raw data - all in one central database. Watson LIMS is the leading bioanalytical LIMS, relied upon by 18 of the top 20 pharmaceutical companies, as well as leading clinical research organizations (CROs) worldwide.

Watson is a highly specialized, protocol-driven software application designed to support drug metabolism and pharmacokinetic (DMPK) studies in drug discovery and development. Pharmaceutical companies and CROs worldwide that standardize on Thermo Scientific Watson LIMS can count on secure data transmissions, regulatory compliance, reliable audit trails and improved time to market.

Comets which consist of two parts, like Chury, can form after a catastrophic collision of larger bodies. Such collisions may have taken place in a later phase of our solar system, which suggests that Chury can be much younger than previously assumed. This is shown through computer simulations.

For the first time, scientists have been able to measure a specific molecule indicative of osteoarthritis and a number of other inflammatory diseases using a newly developed technology. This preclinical study used a solid-state nanopore sensor as a tool for the analysis of hyaluronic acid.